tldrdailynews.com logo

FDA Approves First Oral GLP-1 Weight Loss Pill from Novo Nordisk

1 min read
Source: CNBC
FDA Approves First Oral GLP-1 Weight Loss Pill from Novo Nordisk
Photo: CNBC
TL;DR

The FDA has approved the first oral GLP-1 pill for obesity from Novo Nordisk, expected to launch in early 2026, offering a new treatment option that could expand access and compete with Eli Lilly in the booming weight loss drug market.

Topics:businesshealth#fda-approval#glp-1-pill#health#novo-nordisk#obesity#weight-loss
Share this article
  1. FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk  CNBC
  2. Novo Nordisk wins US approval for weight-loss pill  Reuters
  3. With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins  CNN
  4. Novo Nordisk Gets US Approval for Wegovy Obesity Pill  Bloomberg.com
  5. GLP-1 pills are on the way. Here's what to know : Short Wave  NPR

Want the full story? Read the original reporting

Read on CNBC